RecOVARY? Using anti-Mullerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer. Symonds LK, Davidson NE. J Natl Cancer Inst 2025 Sep 26:djaf247. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Symonds LK, Davidson NE. RecOVARY? Using anti-Mullerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer. J Natl Cancer Inst 2025 Sep 26:djaf247. doi: 10.1093.
PMID: 41005288